Physician profile
Allison Cook
NPI 1699118414
$3,990.26
in general payments reported to CMS, 2019-2025
42 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $225 · 2021: $821 · 2022: $975 · 2023: $801 · 2024: $574 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,634.50 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $703.14 | 2019-2025 | |
| Abbvie INC. | $466.08 | 2019-2025 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $298.22 | 2021-2025 | |
| Exeltis, USA INC. | $290.61 | 2021-2023 | Slynd |
| Shield Therapeutics INC | $226.98 | 2023-2025 | Accrufer |
| Astellas Pharma US INC | $194.42 | 2023-2025 | Veozah, Myrbetriq |
| Aspira Women'S Health INC | $186.09 | 2021-2023 | Ova1 |
| Gynesonics, INC. | $140.98 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $135.70 | 2021-2023 | Twirla |
| Sage Therapeutics, LLC | $116.28 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $115.64 | 2022-2024 | Wegovy |
| Mylan Pharmaceuticals INC. | $114.88 | 2021-2022 | |
| Channel Medsystems, INC. | $101.33 | 2022 | |
| Therapeuticsmd, INC. | $100.11 | 2020-2022 | |
| Avion Pharmaceuticals | $69.92 | 2019-2021 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $63.31 | 2019-2025 | Aptima |
| Lupin INC. | $55.29 | 2019-2021 | |
| Axonics, INC. | $49.04 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $45.52 | 2021 | |
| Medtronic, INC. | $42.95 | 2022 | |
| Pfizer INC. | $41.57 | 2022-2025 | |
| Myovant Sciences INC. | $41.23 | 2022 | |
| Sumitomo Pharma America, INC. | $35.54 | 2023 | Myfembree |
| Lilly USA, LLC | $34.66 | 2024-2025 | Zepbound |
| Coopersurgical, INC. | $34.08 | 2019-2024 | Paragard T 380a |
| Heron Therapeutics, INC. | $30.69 | 2024 | Zynrelef |
| Exact Sciences Corporation | $30.00 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $27.34 | 2020 | |
| Becton, Dickinson and Company | $19.22 | 2023 | Bd Surepath Collection Vial |
| Radius Health, INC. | $17.75 | 2024 | Tymlos |
| Glaxosmithkline, LLC. | $17.28 | 2025 | Pediarix, Bexsero |
| Millicent US INC | $16.73 | 2024 | Intrarosa |
| Ethicon US, LLC | $15.95 | 2020 | |
| Organon LLC | $15.00 | 2024 | |
| Supernus Pharmaceuticals, INC. | $14.62 | 2025 | Qelbree |
| Minerva Surgical, INC | $13.85 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $13.25 | 2019 | |
| Bard Peripheral Vascular, INC. | $13.14 | 2024 | Arista Ah Flexitip |
| Duchesnay USA Incorporated | $12.83 | 2019 | |
| Currax Pharmaceuticals LLC | $12.49 | 2022 | |
| Amag Pharmaceuticals, INC. | $10.84 | 2019 | |
| Meditrina | $5.71 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.